2369 Results
3

UC engineering students help Venti-Now develop low-cost ventilators

July 8, 2020

Two University of Cincinnati biomedical engineering students, Jacquelyn Chapman and Johnathan Wisecarver, are making a tangible impact working with Venti-Now, a nonprofit, start-up company launched in Cincinnati in response to the COVID-19 pandemic to develop a new low-cost ventilators that could be used in impoverished areas. Their professor, Peter Campbell, lends his expertise as medical team leader. UC Health and UC's College of Engineering and Applied Science helped provide Venti-Now with medical testing and consultation.

6

UC finds ancient Maya reservoirs contained toxic pollution

June 26, 2020

A diverse team of biologists, chemists, anthropologists and geographers from the University of Cincinnati identified toxic mercury and algae in two central reservoirs of Tikal, an ancient Maya city, in the ninth century shortly before the city was abandoned.

8

UC cybersecurity research inspires Congressional action

July 21, 2020

The University of Cincinnati College of Arts and Sciences’ cybersecurity community is voicing its full support for a Congressional amendment to the 2021 National Defense Authorization Act to help strengthen cyber security protection advancements nationwide. Introduced last week by U.S. Representatives Steve Chabot (R-Westwood), Mike Turner (R-Dayton) and Marcia Fudge (D-Cleveland), and passed Monday, July 20th by the U.S. House of Representatives, the amendment secures $3 million in funding for the National Center for Hardware and Embedded Systems Security and Trust (CHEST).

10

UC researcher examines genetic role in addiction

October 12, 2020

In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits. Pharmacogenomics, a relatively new field, is the study of how genes affect a person's response to drugs.